Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4042885019 | Pralsetinib (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4042886018 | Pralsetinib | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Pralsetinib (substance) | Is a | Enzyme inhibitor | false | Inferred relationship | Some | ||
| Pralsetinib (substance) | Is a | Pyridine | true | Inferred relationship | Some | ||
| Pralsetinib (substance) | Has disposition (attribute) | Protein-tyrosine kinase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Pralsetinib (substance) | Is a | Protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Pralsetinib (substance) | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Pralsetinib only product | Has active ingredient | True | Pralsetinib (substance) | Inferred relationship | Some | 1 |
| Pralsetinib-containing product | Has active ingredient | True | Pralsetinib (substance) | Inferred relationship | Some | 1 |
| Pralsetinib-containing product in oral dose form | Has active ingredient | True | Pralsetinib (substance) | Inferred relationship | Some | 1 |
| Pralsetinib only product in oral dose form | Has active ingredient | True | Pralsetinib (substance) | Inferred relationship | Some | 1 |
| Product containing precisely pralsetinib 100 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Pralsetinib (substance) | Inferred relationship | Some | 1 |
| Product containing precisely pralsetinib 100 milligram/1 each conventional release oral capsule (clinical drug) | Has basis of strength substance (attribute) | True | Pralsetinib (substance) | Inferred relationship | Some | 1 |
Reference Sets
FHIR